1. Pediatric high-grade glioma: aberrant epigenetics and kinase signaling define emerging therapeutic opportunities
   Yusha Sun et al, 2020, Journal of Neuro-Oncology CrossRef
2. Recent Advances in Understanding the Role of Autophagy in Paediatric Brain Tumours
   Francesca Gatto et al, 2021, Diagnostics CrossRef
3. Therapeutic Targets in Diffuse Midline Gliomas—An Emerging Landscape
   Elisha Hayden et al, 2021, Cancers CrossRef
4. Radiosensitization in Pediatric High-Grade Glioma: Targets, Resistance and Developments
   Dennis S. Metselaar et al, 2021, Frontiers in Oncology CrossRef
5. MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas
   Hideaki ABE et al, 2018, Neurologia medico-chirurgica CrossRef
6. Evidence-Based Practice: Temozolomide Beyond Glioblastoma
   Jason Chua et al, 2019, Current Oncology Reports CrossRef
7. Small Molecule Inhibitors in Adult High-Grade Glioma: From the Past to the Future
   Wenda Huang et al, 2022, Frontiers in Oncology CrossRef
8. Glioblastoma: Current Status, Emerging Targets, and Recent Advances
   Amandeep Thakur et al, 2022, Journal of Medicinal Chemistry CrossRef